Time course of transforming growth factor-β1 (TGF-β1) mRNA expression in the host reaction to alginate-poly-L-lysine microcapsules following implantations into rat epididymal fat pads

Journal of Biomedical Materials Research

Volumn 52, Issue 1, 2000, Pages 18-23

  Robitaille, Robert ^a   Desbiens, Karine ^a   Henley, Nathalie ^a   Hallé, Jean Pierre ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Biocompatibility; Host reaction; Microcapsules; TGF 1, time course

Indexed keywords

BIOCOMPATIBILITY; CELLS; COLLAGEN; ENZYMES; GRAFTS; GROWTH KINETICS; PROTEINS; TRANSPLANTATION (SURGICAL);

CYTOKINES; EPIDIDYMAL FAT PADS; ISLETS OF LANGERHANS; MICROENCAPSULATION; MRNA EXPRESSION; PATHOGENESIS; PERICAPSULAR HOST REACTION; TRANSFORMING GROWTH FACTORS;

RNA;

ALGINIC ACID; POLYLYSINE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDIDYMIS FAT; GRAFT FAILURE; GRAFT REJECTION; MESSENGER RNA SYNTHESIS; MICROCAPSULE; MICROENCAPSULATION; NONHUMAN; PATHOGENESIS; RAT;

EID: 0034255616     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4636(200010)52:1<18::AID-JBM3>3.0.CO;2-J     Document Type: Article

References (49)

1. Chang TMS, Semipermeable microcapsules. Science 1964;146: 524-526.
2. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908-910.
3. Soon-Shiong P, Lu Z-N, Grewal I, Lanza RP, Clark W. An in vitro method of assessing the immunoprotective properties of microcapsule membranes using pancreatic and tumor cell targets. Transplant Proc 1990;22:754-755.
4. Soon-Shiong P, Lu Z-N, Grewal I, Lanza R, Clark W. Prevention of CTL and NK cell-mediated cytotoxicity by microencapsulation. Horm Metab Res 1990;25(Suppl 1):215-219.
5. Hallé J-P, Bourassa S, Leblond FA, Chevalier S, Beaudry M, Chapdelaine A, Cousineau S, Saintonge J, Yale J-F. Protection of islets of Langerhans from antibodies by microencapsulation with alginate-poly L-lysine microcapsules. Transplantation 1993;55:350-354.
6. Soon-Shiong P, Heintz R, Yao Z, Yao Q, Sanford P, Lanza RP, Meredith N. Glucose-insulin kinetics of the extravascular bioartificial pancreas: A study using microencapsulated rat islets. ASAIO J 1992;38:851-854.
7. Ricker A, Stockberger S. Hyperimmune response to microencapsulated xenogenic tissue in NOD mice. Diabetes 1986;35(Suppl 1):61A.
8. Darquy S, Chicheportiche D, Capron F, Boitard C, Reach G. Comparative study of microencapsulated rat islets implanted in different diabetic models in mice. Horm Metab Res Suppl 1990;25:209-213.
9. Weber CJ, Zabinski S, Koschitzky T, Wicker L, Rajotte R, D'Agati V, Peterson L, Norton J, Reemtsma K. The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice. Transplantation 1990;49:396-404.
10. Lum Z-P, Krestow M, Tai IT, Vacek I, Sun AM Xenografts of rat islets into diabetic mice. Transplantation 1992;53:1180-1183.
11. De Vos P, de Haan BJ, Pater J, van Schilfgaarde R. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. Transplantation. 1996;62:893-899.
12. Cole DR, Waterfall M, McIntyre M, Baird JD. Microencapsulated islet grafts in the BB/E rat: A possible role for cytokines in graft failure. Diabetologia 1992;35:231-237.
13. Fritschy WM, De Vos P, Groen H, Klatter FA, Pasma A, Wolters GHJ, Van Schilfgaarde R. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transplant Int 1994;7:264-271.
14. De Vos P, De Haan B, Wolters GHJ, Van Schilfgaarde R. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. Transplantation 1996;62:888-893.
15. Van Schilfgaarde R, De Vos P. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med 1999;77:199-205.
16. Van Schilfgaarde R, De Vos P. Aspects of immunoprotection of islets. Transplant Proc 1996;28:3516-3517.
17. Lum Z-P, Tai IT, Krestow M, Norton J, Vacek I, Sun AM. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 1991;40:1511-1515.
18. Colton CK, Avgoustiniatos ES. Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng 1991;113:152-170.
19. Lanza RP, Borland KM, Staruk JE, Appel MC, Solomon HA, Chick WL. Transplantation of encapsulated canine islets into spontaneously diabetic BB/W or rats without immunosuppression. Endocrinology 1992;131:637-642.
20. Otterlei M, Ostgaard K, Skjak-Braek G, Smidsrod O, Soon-Shiong P, Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J Immunother 1991;10:286-291.
21. Pueyo ME, Darquy S, Capron F, Reach G. In vitro activation of human macrophages by alginate-polylysine microcapsules. J Biomater Sci Polym 1993;5:197-203.
22. Zimmermann U, Klock G, Federlin K, Hannig K, Kowalski M, Bretzel RG, Horcher A, Entenmann H, Sieber U, Zekorn T. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 1992;13:269-274.
23. Wijsman J, Atkinson P, Mazaheri R, Garcia B, Paul T, Vose J, O'Shea G, Stiller C. Histological and immunopathological analysis of recovered encapsulated allogenic islets from transplanted diabetic BB/W rats. Transplantation 1992;54:588-592.
24. Kovacs EJ. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
25. Kovacs EJ, Dipietro LA. Fibrogenic cytokines and connective tissue production. FASEB J 1994;8:854-861.
26. Border WA, Noble NA. Transforming growth factor B in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
27. Robitaille R, Leblond FA, Henley N, Prud'homme GJ, Drobetsky E, Hallé J-P. Alginate-poly-L-lysine microcapsule biocompatibility: A novel method for cytokine gene expression analysis in pericapsular infiltrates. J Biomed Mater Res 1999; 45:223-230.
28. Hallé J-P, Leblond FA, Pariseau J-F, Jutras P, Brabant M-J, Lepage Y. Studies on small (<300 μm) microcapsules. II. Parameters governing the production of alginate beads by high voltage electrostatic pulses. Cell Transplant 1994;3:365-372.
29. Sun AM, O'Shea GM. Microencapsulation of living cells: A long-term delivery system. J Controlled Release 1985;2:137-141.
30. Pariseau J-F, Leblond FA, Harel F, Lepage Y, Hallé J-P. The rat epididymal fat pad as an implantation site for the study of microcapsule biocompatibility: Validation of the method. J Biomed Mater Res 1995;29:1331-1335.
31. Robitaille R, Leblond FA, Bourgeois Y, Henley N, Loignon M, Hallé J-P. Studies on small (<350 μm) alginate-poly-L-lysine microcapsules. V. Determination of carbohydrate and proteins permeation through microcapsules by reverse size exclusion chromatography. J Biomed Mater Res, to appear.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
33. Ignotz RA, Endo T, Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-B. J Biol Chem 1986;262:6443-6446.
34. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor type B: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
35. Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen W-T, Yamada KM, McDonald JA. Transforming growth factor B stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem 1988;263:4586-4592.
36. Wokalek H, Ruh H. Time course of wound healing. J Biomater Appl 1991;5:337-362.
37. Lammers RL. Soft tissue foreign bodies: Annals of emergency medicine 1988;17:1336-1347.
38. Katou F, Ohtani H, Nagura H, Motegi K. Procollagen-positive fibroblasts predominantly express fibrogenic growth factors and their receptors in human encapsulation process against foreign body. J Pathol 1998;186:201-208.
39. Lossing C, Hansson H-A. Peptide growth factors and myofibroblasts in capsules around human breast implants. Plast Reconstr Surg 1993;91:1277-1286.
40. Anderson JM. Inflammatory response to implants. Trans Am Soc Artif Int Org 1988;XXXIV:101-107.
41. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-6024.
42. Weber C, Ayres-Price J, Constanzo M, Becker A, Stall A. NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets. Transplant Proc 1994:26:1116-1119.
43. Jesser C, Kessler L, Lambert A, Belcourt A, Pinget M. Pancreatic islet macroencapsulation: A new device for the evaluation of artificial membrane. Artif Organs 1996;20:997-1007.
44. Kessler L, Jesser C, Lombard Y, Karsten V, Belcourt A, Pinget M, Poindron P. Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: In vivo and in vitro studies. J Leukocyte Biol 1996;60:729-736.
45. De Vos P, Wolters GHJ, Van Schilfgaarde R. Possible relationship between fibrotic overgrowth of alginate-polylysine-alginate microencapsulated pancreatic islets and the microcapsule integrity. Transplant Proc 1994;26:782-783.
46. Hsu BRS, Ho YS, Fu SH, Huang YY, Chiou SC, Huang HS. Membrane compactness affects the integrity and immunoprotection of alginate-poly-L-lysine-alginate microcapsules. Transplant Proc 1995;27:3227-3231.
47. Colton CK. Implantable biohybrid artificial organs. Cell Transplant 1995;4:415-436.
48. Lanza RP, Beyer AM, Chick WL. Xenogeneic humoral responses to islets transplanted in biohybrid diffusion chambers. Transplantation 1994;57:1371-1375.
49. Fraser RB, MacAulay MA, Wright JR, Sun AM, Rowden G. Migration of macrophage-like cells within encapsulated islets of Langerhans maintained in tissue culture. Cell Transplant 1995;4:529-534.